Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Epigenetics of cancer and changes in DNA modification in tumours

Prof Manel Esteller – University of Barcelona, Catalonia, Spain
Epigenetics of cancer and changes in DNA modification in tumours  ( Prof Manel Esteller – University of Barcelona, Catalonia, Spain   )
16 Jul 2012

Perifosine disappoints in refractory mCRC

Dr Johanna Bendell – Sarah Cannon Research Institute, Nashville, USA
Perifosine disappoints in refractory mCRC ( Dr Johanna Bendell – Sarah Cannon Research Institute, Nashville, USA )
16 Jul 2012

Tivantinib first drug to have overall survival benefit as second-line hepatocellular carcinoma treatment

Dr Camillo Porta – Fondazione IRCCS Policlinico Universitario San Matteo, Pavia, Italy
Tivantinib first drug to have overall survival benefit as second-line hepatocellular carcinoma treatment ( Dr Camillo Porta – Fondazione IRCCS Policlinico Universitario San Matteo, Pavia, Italy )
16 Jul 2012

Advances in radiotherapy for rectal cancer

Dr Karin Haustermans – University Hospital Leuven, Belgium
Advances in radiotherapy for rectal cancer  ( Dr Karin Haustermans – University Hospital Leuven, Belgium )
16 Jul 2012

A new direction for development of targeted cancer therapies

Dr Edison Liu – Jackson Laboratory, USA
A new direction for development of targeted cancer therapies ( Dr Edison Liu – Jackson Laboratory, USA )
16 Jul 2012

Application of next generation sequencing

Dr Gary Palmer – Foundation Medicine, Cambridge, USA
Application of next generation sequencing ( Dr Gary Palmer – Foundation Medicine, Cambridge, USA )
6 Jul 2012

Next generation sequencing and WIN therapeutics

Dr Michael Pellini – Foundation Medicine, Cambridge, USA
Next generation sequencing and WIN therapeutics ( Dr Michael Pellini – Foundation Medicine, Cambridge, USA )
6 Jul 2012

Identifying targets with systems medicine

Dr Leroy Hood – Institute for Systems Biology, USA
Identifying targets with systems medicine ( Dr Leroy Hood – Institute for Systems Biology, USA )
6 Jul 2012

Shortening the timeline for clinical drug developments

Dr James Doroshow – National Cancer Institute, Bethesda, USA
Shortening the timeline for clinical drug developments ( Dr James Doroshow – National Cancer Institute, Bethesda, USA )
6 Jul 2012

Building international collaborations and the WINTHER trial

Dr Oliver Bogler – MD Anderson Cancer Center, Houston, USA
Building international collaborations and the WINTHER trial ( Dr Oliver Bogler – MD Anderson Cancer Center, Houston, USA )
6 Jul 2012

GFI is crucial for AML1-ETO induced acute myeloid leukemia

Dr Bert van der Reijden – Radboud University Nijmegen Medical Centre, Holland
GFI is crucial for AML1-ETO induced acute myeloid leukemia ( Dr Bert van der Reijden – Radboud University Nijmegen Medical Centre, Holland )
26 Jun 2012

Signaling and targeting cellular pathways in leukaemia metabolism

Dr Jing Chen – Emory University School of Medicine, Atlanta, USA
Signaling and targeting cellular pathways in leukaemia metabolism ( Dr Jing Chen – Emory University School of Medicine, Atlanta, USA )
26 Jun 2012